Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
urinderiveret fsh (n = 116)
urinary fsh (n = 116)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
det har samme aminosyresekvens som urinderiveret hcg.
it shares the amino acid sequence with urinary hcg.
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
dosisanbefalingerne for follitropin alfa er de samme som for urinderiveret fsh.
the dose recommendations given for follitropin alfa are those in use for urinary fsh.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
dosisanbefalingerne for gonal-f er de samme som for urinderiveret fsh.
the dose recommendations given for gonal-f are those in use for urinary fsh.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
den farmakokinetiske profil af lutropin alfa er tilsvarende den hos urinderiveret hlh.
the pharmacokinetic profile of lutropin alfa is similar to that of urinary-derived hlh.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
5 den farmakokinetiske profil af lutropin alfa er tilsvarende den hos urinderiveret hlh.
following
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
den farmakokinetiske profil af lutropin alfa svarer til den farmakokinetiske profil af urinderiveret hlh.
the pharmacokinetic profile of lutropin alfa is similar to that of urinary- derived hlh.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sikkerhedsprofilen på luveris forventes at være meget lig den på urinderiveret hlh med undtagelse af evt. overfølsomhed og reaktioner på injektionstedet.
the safety profile of luveris is expected to be very similar to that of urine derived hlh, with the exception of hypersensitivity reactions and application site disorders.
Last Update: 2012-04-11
Usage Frequency: 3
Quality:
til dags dato er der ikke nogen klinisk erfaring med ovitrelle ved andre indikationer, der normalt behandles med urinderiveret humant choriogonadotropin.
to date, there is no clinical experience with ovitrelle in other indications commonly treated with urine derived human chorionic gonadotrophin.
Last Update: 2012-04-12
Usage Frequency: 3
Quality:
på baggrund af resultater fra sammenlignende kliniske studier anbefales det at give en lavere dosis fertavid sammenlignet med den dosis urinderiveret fsh, der generelt bruges.
especially when switching from a syringe to the pen, small dose adjustments may be needed to prevent too high a dose being given.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
ved ovulations-induktion resulterede behandling med follitropin beta i en lavere gennemsnitlig total- dosis og kortere gennemsnitlig behandlingsvarighed sammenlignet med urinderiveret fsh.
for ovulation induction, follitropin beta resulted in a lower median total dose and shorter median duration of treatment when compared to urinary fsh.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
100 i sammenlignende kliniske studier med puregon og urinderiveret fsh blev det vist, at puregon er mere effektivt end urinderiveret fsh, hvad angår en lavere total dosis og en kortere behandlingstid med henblik på opnåelse af præovulatoriske forhold.
100 in comparative clinical studies with puregon and urinary fsh it was shown that puregon is more effective than urinary fsh in terms of a lower total dose and a shorter treatment period needed to achieve pre-ovulatory conditions.
Last Update: 2008-03-04
Usage Frequency: 15
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
derfor anbefales det at give en lavere dosis puregon sammenlignet med den dosis urinderiveret fsh, der generelt bruges, ikke kun med henblik på at optimere udviklingen af follikler, men også for at minimere risikoen for uønsket ovariehyperstimulation.
therefore, it is considered appropriate to give a lower dosage of puregon than generally used for urinary fsh, not only in order to optimise follicular development but also to minimise the risk of unwanted ovarian hyperstimulation.
Last Update: 2008-03-04
Usage Frequency: 14
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
100 på baggrund af resultater fra sammenlignende kliniske studier anbefales det at give en lavere dosis puregon sammenlignet med den dosis urinderiveret fsh, der generelt bruges, ikke kun med henblik på at optimere udviklingen af follikler, men også for at minimere risikoen for uønsket ovariehyperstimulation.
90 based on the results of comparative clinical studies, it is considered appropriate to give a lower dosage of puregon than generally used for urinary fsh, not only in order to optimise follicular development but also to minimise the risk of unwanted ovarian hyperstimulation.
Last Update: 2012-04-12
Usage Frequency: 5
Quality:
tabel: resultaterne af studie gf 8407 (randomiseret parallelgruppestudie, der sammenligner effekt og sikkerhed af gonal-f med urinderiveret fsh i assisterede reproduktionsteknologier).
table: results of study gf 8407 (randomised parallel group study comparing efficacy and safety of gonal-f with urinary fsh in assisted reproduction technologies)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
12 kliniske vurderinger af gonal- f indikerer, at dens daglige dosis, administrations kuren og monitoreringsproceduren ikke skal være anderledes end hvordan man behandler med urinderiverede fsh (u- fsh) præparater.
clinical assessment of gonal-f indicates that its daily doses, regimens of administration, and treatment monitoring procedures should not be different from those currently used for urinary fsh-containing preparations.
Last Update: 2012-04-11
Usage Frequency: 6
Quality: